Stay updated on PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.

Latest updates to the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check16 days agoChange DetectedA banner announces that NIH is transitioning to use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with updates and FAQs available.SummaryDifference0.7%

- Check22 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check29 days agoChange DetectedThe ClinicalTrials.gov interface revision displayed in the footer changes from v3.7.0 to v3.7.1; the study record history remains unchanged.SummaryDifference0.1%

- Check51 days agoChange DetectedA new software Revision: v3.7.0 entry was added to the record history and the previous Revision: v3.6.6 entry was removed. This indicates an update to the revision-tracking system used on the page, rather than a change to study data.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibition Effect on CV Risk in Treated HIV Clinical Trial page.